336 related articles for article (PubMed ID: 26193962)
41. Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA).
Milovanov V; Sardi A; Ledakis P; Aydin N; Nieroda C; Sittig M; Nunez M; Gushchin V
Eur J Surg Oncol; 2015 May; 41(5):707-12. PubMed ID: 25633641
[TBL] [Abstract][Full Text] [Related]
42. The modified Glasgow prognosis score predicts for overall and disease-free survival following cytoreductive surgery and HIPEC in patients with pseudomyxoma peritonei of appendiceal origin.
Tan GH; Novo CA; Dayal S; Chandrakumaran K; Mohamed F; Cecil T; Moran BJ
Eur J Surg Oncol; 2017 Feb; 43(2):388-394. PubMed ID: 27866811
[TBL] [Abstract][Full Text] [Related]
43. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
Lord AC; Shihab O; Chandrakumaran K; Mohamed F; Cecil TD; Moran BJ
Eur J Surg Oncol; 2015 Mar; 41(3):396-9. PubMed ID: 25216980
[TBL] [Abstract][Full Text] [Related]
44. [Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy].
Scuderi S; Costamagna D; Vaira M; Barone R; De Simone M
Tumori; 2003; 89(4 Suppl):43-5. PubMed ID: 12903542
[TBL] [Abstract][Full Text] [Related]
45. Treatment of pseudomyxoma peritonei with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a single center experience.
Robella M; Vaira M; Marsanic P; Mellano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2013 Dec; 68(6):569-77. PubMed ID: 24193289
[TBL] [Abstract][Full Text] [Related]
46. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome.
Brouquet A; Goéré D; Lefèvre JH; Bonnet S; Dumont F; Raynard B; Elias D
Ann Surg Oncol; 2009 Oct; 16(10):2744-51. PubMed ID: 19626375
[TBL] [Abstract][Full Text] [Related]
47. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.
Witkamp AJ; de Bree E; Kaag MM; van Slooten GW; van Coevorden F; Zoetmulder FA
Br J Surg; 2001 Mar; 88(3):458-63. PubMed ID: 11260116
[TBL] [Abstract][Full Text] [Related]
48. Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study.
Jess P; Iversen LH; Nielsen MB; Hansen F; Laurberg S; Rasmussen PC
Dis Colon Rectum; 2008 Jun; 51(6):868-74. PubMed ID: 18297361
[TBL] [Abstract][Full Text] [Related]
49. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
[TBL] [Abstract][Full Text] [Related]
50. Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Baratti D; Kusamura S; Milione M; Bruno F; Guaglio M; Deraco M
Ann Surg Oncol; 2018 Feb; 25(2):404-413. PubMed ID: 29159742
[TBL] [Abstract][Full Text] [Related]
51. Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei.
Dang A; Mansfield P; Ilsin B; Hightower C; Aravindan N; Rice D; Riedel B
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):265-8. PubMed ID: 17418746
[No Abstract] [Full Text] [Related]
52. Outcome of patients with aggressive pseudomyxoma peritonei treated by cytoreductive surgery and intraperitoneal chemotherapy.
Arjona-Sanchez A; Muñoz-Casares FC; Casado-Adam A; Sánchez-Hidalgo JM; Ayllon Teran MD; Orti-Rodriguez R; Padial-Aguado AC; Medina-Fernández J; Ortega-Salas R; Pulido-Cortijo G; Gómez-España A; Rufián-Peña S
World J Surg; 2013 Jun; 37(6):1263-70. PubMed ID: 23532601
[TBL] [Abstract][Full Text] [Related]
53. Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer.
Cashin PH; Mahteme H; Graf W; Karlsson H; Larsson R; Nygren P
BMC Cancer; 2013 Sep; 13():435. PubMed ID: 24063788
[TBL] [Abstract][Full Text] [Related]
54. Pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic chemotherapy: a 7-year single-center experience.
Virzì S; Iusco D; Bonomi S; Grassi A
Tumori; 2012; 98(5):588-93. PubMed ID: 23235753
[TBL] [Abstract][Full Text] [Related]
55. Preoperative carcinoembryonic antigen level predicts prognosis in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Canbay E; Ishibashi H; Sako S; Mizumoto A; Hirano M; Ichinose M; Takao N; Yonemura Y
World J Surg; 2013 Jun; 37(6):1271-6. PubMed ID: 23467926
[TBL] [Abstract][Full Text] [Related]
56. [Pseudomyxoma peritonei: new concept and new therapeutic approach].
Loungnarath R; Causeret S; Brigand C; Gilly FN; Glehen O
Ann Chir; 2005 Feb; 130(2):63-9. PubMed ID: 15737316
[TBL] [Abstract][Full Text] [Related]
57. [Pseudomyxoma peritonei; a rare tumour that can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Smeenk RM; Verwaal VJ; Zoetmulder FA
Ned Tijdschr Geneeskd; 2007 Feb; 151(7):418-23. PubMed ID: 17343142
[TBL] [Abstract][Full Text] [Related]
58. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.
Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E
Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429
[TBL] [Abstract][Full Text] [Related]
59. Early Postoperative Intraperitoneal Chemotherapy for Low-Grade Appendiceal Mucinous Neoplasms with Pseudomyxoma Peritonei: Is it Beneficial?
Huang Y; Alzahrani NA; Liauw W; Traiki TB; Morris DL
Ann Surg Oncol; 2017 Jan; 24(1):176-183. PubMed ID: 27718032
[TBL] [Abstract][Full Text] [Related]
60. Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin.
Zoetmulder FA; Sugarbaker PH
Eur J Cancer; 1996 Sep; 32A(10):1727-33. PubMed ID: 8983281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
